Navigation Links
New Treatment Eyed for Ewing's Sarcoma
Date:12/24/2009

Figitumumab fights tumors and appears to be well-tolerated, researchers say

WEDNESDAY, Dec. 23 (HealthDay News) -- Preliminary research suggests that the anticancer drug figitumumab might be an effective treatment for Ewing's sarcoma, a cancer that affects the areas in and near the bone, mainly in teenage boys.

The drug must undergo two more phases of testing, however, according to a report published in the Dec. 23 online edition of The Lancet Oncology.

In the first phase of research, scientists looked at 29 patients with advanced sarcomas who received the drug between 2006 and 2008. The researchers wanted to assess its safety and ability to be tolerated.

Patients did experience some side effects, such as deep venous thrombosis, back pain and vomiting. Some of the patients appeared to respond well to the drug, the study authors noted.

"Figitumumab is well-tolerated and has antitumor activity in Ewing's sarcoma, warranting further investigation in this disease," the researchers wrote. "Our results show that figitumumab can be safe for both adult and pediatric sarcoma patients, and has single-agent antitumor activity in different sarcoma subtypes, including Ewing's sarcoma."

In a commentary accompanying the study, doctors wrote that "five-drug chemotherapy is routine in the treatment of Ewing's sarcoma, therefore improvement in outcome for these patients will likely require demonstration of the feasibility of combining the antibody with standard chemotherapy."

More information

The U.S. National Library of Medicine has more on Ewing's sarcoma.



-- Randy Dotinga



SOURCE: The Lancet Oncology, news release, Dec. 23, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Modernizing the treatment of sexual dysfunction in men
2. Autism Treatment Crisis: Insufficient Number of Providers to Meet Alarming Increase in Need
3. New insights into mushroom-derived drug promising for cancer treatment
4. Protein link may be key to new treatment for aggressive brain tumor
5. Michael J. Fox Foundation Awards $1 Million for Critical Step Toward Development of Dyskinesia Treatments
6. Diabetes Insight Could Lead to Better Treatments
7. IBS Treatment Center Calls on McCain to Support IBS Research
8. Targeting brain cancer cell metabolism may provide new treatment
9. Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail
10. Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling
11. Early Treatment of Hearing, Vision Helps in Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... Irvine, CA — , ... ... the appointment of three new members of its Advisory Board. ... Chico and Sarah Kusch. “All three of them embody the mission ... team. We are very fortunate to have them as we continue ...
(Date:5/24/2016)... ... May 24, 2016 , ... Boyd Industries, a leading supplier of ... a groundbreaking new product for pediatric dentistry , at AAPD 2016, the annual ... TX May 26-29. The Concealed Delivery Unit keeps dental hand pieces and other anxiety-provoking ...
(Date:5/24/2016)... ... May 24, 2016 , ... Eggsurance, the first ... relaunch of its community and education hub for women considering fertility preservation, as ... create a safe and welcoming place for women to find cycle buddies, get ...
(Date:5/24/2016)... ... May 24, 2016 , ... American Gene Technologies ... to its board of directors. Otterstatter is co-founder, president and CEO of ... technological innovations that lead to broad-based healthcare solutions. , “Jon knows how to ...
(Date:5/24/2016)... ... May 24, 2016 , ... Bio-Logic Aqua® Research Water Life ... and a trainer for Ageless Grace ( http://www.agelessgrace.com ) to discuss healthier lifestyles, ... 16, 2016. , Formerly a Northwestern University Literature Professor, Kinst gravitated to her ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... as senior vice president of sales, announced Andrea Heslin Smiley , VMS president ... business development and sales team, exploring new opportunities for VMS to empower patients and ... ... ... ...
(Date:5/24/2016)... Open Access Journal Focusing ... Elsevier , a world-leading provider of scientific, ... the launch of Clinical Neurophysiology ... on clinical practice issues in clinical neurophysiology. The journal ... values and didactic reviews. It is an official journal ...
(Date:5/23/2016)... 2016 Global Paclitaxel Market 2016 ... 12 companies and the Paclitaxel analysis in this study ... industry and its players. This is the ... details the current state of the industry while providing ... applications and industry chain structure. The Paclitaxel market analysis ...
Breaking Medicine Technology: